Luigi Nibali1,2, Vanessa Sousa2, Mehmet Davrandi3, David Spratt3, Qumasha Alyahya4, Jose Dopico5, Nikos Donos2. 1. Periodontology Unit, Centre for Host Microbiome Interactions, Faculty of Dentistry, Oral & Craniofacial Sciences, King's College London, London, UK. 2. Centre for Oral Immunobiology & Regenerative Medicine & Centre for Oral Clinical Research, Institute of Dentistry, Barts and The London School of Medicine and Dentistry, Queen Mary University London, London, UK. 3. Microbial Diseases Department, University College London Eastman Dental Institute, London, UK. 4. Periodontology Unit, University College London Eastman Dental Institute, London, UK. 5. Periodontics Department, Universidad de Santiago de Compostela, Santiago de Compostela, Spain.
Abstract
AIMS: The primary aim of this investigation was to analyse the periodontal microbiome in patients with aggressive periodontitis (AgP) following treatment. METHODS: Sixty-six AgP patients were recalled on average 7 years after completion of active periodontal treatment and had subgingival plaque samples collected and processed for 16S rRNA gene sequencing analyses. RESULTS: Of 66 participants, 52 showed persistent periodontal disease, while 13 participants were considered as "successfully treated AgP" (no probing pocket depths >4 mm) and 1 was fully edentulous. Genera associated with persistent generalized disease included Actinomyces, Alloprevotella, Capnocytophaga, Filifactor, Fretibacterium, Fusobacterium, Leptotrichia, Mogibacterium, Saccharibacteria [G-1], Selenomonas and Treponema. "Successfully treated" patients harboured higher proportions of Haemophilus, Rothia, and Lautropia and of Corynebacterium, Streptococcus and Peptidiphaga genera. Overall, patients with persistent generalized AgP (GAgP) revealed higher alpha diversity compared to persistent localized AgP (LAgP) and stable patients (p < .001). Beta diversity analyses revealed significant differences only between stable and persistent GAgP groups (p = .004). CONCLUSION: Patients with persistent AgP showed a more dysbiotic subgingival biofilm than those who have been successfully treated. It remains to be established whether such differences were predisposing to disease activity or were a result of a dysbiotic change associated with disease recurrence in the presence of sub-standard supportive periodontal therapy or other patient-related factors.
AIMS: The primary aim of this investigation was to analyse the periodontal microbiome in patients with aggressive periodontitis (AgP) following treatment. METHODS: Sixty-six AgP patients were recalled on average 7 years after completion of active periodontal treatment and had subgingival plaque samples collected and processed for 16S rRNA gene sequencing analyses. RESULTS: Of 66 participants, 52 showed persistent periodontal disease, while 13 participants were considered as "successfully treated AgP" (no probing pocket depths >4 mm) and 1 was fully edentulous. Genera associated with persistent generalized disease included Actinomyces, Alloprevotella, Capnocytophaga, Filifactor, Fretibacterium, Fusobacterium, Leptotrichia, Mogibacterium, Saccharibacteria [G-1], Selenomonas and Treponema. "Successfully treated" patients harboured higher proportions of Haemophilus, Rothia, and Lautropia and of Corynebacterium, Streptococcus and Peptidiphaga genera. Overall, patients with persistent generalized AgP (GAgP) revealed higher alpha diversity compared to persistent localized AgP (LAgP) and stable patients (p < .001). Beta diversity analyses revealed significant differences only between stable and persistent GAgP groups (p = .004). CONCLUSION:Patients with persistent AgP showed a more dysbiotic subgingival biofilm than those who have been successfully treated. It remains to be established whether such differences were predisposing to disease activity or were a result of a dysbiotic change associated with disease recurrence in the presence of sub-standard supportive periodontal therapy or other patient-related factors.
Authors: Charlotte Thomas; Matthieu Minty; Thibault Canceill; Pascale Loubières; Vincent Azalbert; François Tercé; Camille Champion; Rémy Burcelin; Pierre Barthet; Sara Laurencin-Dalicieux; Vincent Blasco-Baque Journal: Diagnostics (Basel) Date: 2021-04-21
Authors: María Martínez; Teodor T Postolache; Borja García-Bueno; Juan C Leza; Elena Figuero; Christopher A Lowry; Stefanie Malan-Müller Journal: Front Psychiatry Date: 2022-01-27 Impact factor: 4.157
Authors: Joel L Schwartz; Natalia Peña; Nadia Kawar; Andrew Zhang; Nicholas Callahan; Steven J Robles; Andrew Griebel; Guy R Adami Journal: BMC Oral Health Date: 2021-10-04 Impact factor: 2.757
Authors: Susanne Schulz; Jamal M Stein; Anne Schumacher; David Kupietz; Sareh S Yekta-Michael; Florian Schittenhelm; Georg Conrads; Hans-Günter Schaller; Stefan Reichert Journal: J Clin Med Date: 2022-02-23 Impact factor: 4.241
Authors: Simone G Oliveira; Rodrigo Jardim; Rafaela R Nishiyama; Claudio A C Trigo; Ana Luiza Mattos-Guaraldi; Alberto M R Dávila; Flavio H B Aguiar Journal: BMC Oral Health Date: 2021-07-16 Impact factor: 2.757
Authors: Sebastian Böttger; Silke Zechel-Gran; Daniel Schmermund; Philipp Streckbein; Jan-Falco Wilbrand; Michael Knitschke; Jörn Pons-Kühnemann; Torsten Hain; Markus Weigel; Hans-Peter Howaldt; Eugen Domann; Sameh Attia Journal: Microorganisms Date: 2021-06-16
Authors: Chun-Teh Lee; Ruoxing Li; Lisha Zhu; Gena D Tribble; W Jim Zheng; Brittney Ferguson; Krishna Rao Maddipati; Nikola Angelov; Thomas E Van Dyke Journal: Front Immunol Date: 2021-06-10 Impact factor: 7.561